Investigator

Chen Chen

Emeritus Chair Professor of Endocrinology and Physiology · The University of Queensland, Faculty of Health, Medicine and Behavioural Sciences

CCChen Chen
Papers(3)
17‐β‐estradiol reduce…miRNA-576-5p promotes…Analysis of Distribut…
Collaborators(5)
Huirong ZhaoLiyuan GuoMeili GongMeiyu SongMingxia Sun
Institutions(3)
The University Of Que…Beijing Chao Yang Hos…Harbin Medical Univer…

Papers

miRNA-576-5p promotes endometrial cancer cell growth and metastasis by targeting ZBTB4

Abstract Purpose MicroRNAs (miRNAs) have already been shown to have a strong correlation with the invasion and metastasis capacity of tumor cells. The present research examined the function of miRNA-576-5p (miR-576-5p) in the development of endometrial cancer (EC). Methods miR-576-5p and ZBTB4 expression in EC and benign endometrial tissues was measured using quantitative real-time PCR (qRT-PCR) and western blot. To evaluate the proliferation ability of tumor cells in vitro, 2,5-diphenyl-2H-tetrazolium bromide (MTT) and colony formation assays were carried out. The effect of miR-576-5p on the proliferation ability of EC cells in vivo was measured by the tumor formation in nude mice. The migration and invasion ability of tumor cells was determined using the transwell assay. To confirm the association between expressions of miR-576-5p and zinc finger and BTB domain containing four (ZBTB4), western blot, qRT-PCR, and luciferase assay were carried out. Results miR-576-5p expression increased significantly in EC samples than in benign endometrial tissues. The level of miR-576-5p was significantly higher in the polymerase ε (POLE) ultramutated subgroup compared to the other three subgroups. High levels of miR-576-5p expression were linked to a shorter progression-free interval time in the copy number high subgroup. Furthermore, upregulated miR-576-5p facilitated EC cell invasion and migration in vitro and promoted the proliferation of EC tumor cell lines both in vitro and in vivo. Moreover, this study showed that the expression of ZBTB4 decreased in patients with EC, and the dual-luciferase reporter assay confirmed that miR-576-5p binds directly to the 3′-UTR of ZBTB4 and inhibits the expression of ZBTB4. An increase in miR-576-5p expression leads to a decrease in the mRNA and protein expression level of ZBTB4. The effects of miR-576-5p can be reversed by overexpression of ZBTB4. Conclusion miR-576-5p promoted proliferation and metastasis capacity of EC cells by inhibiting ZBTB4 expression. We hypothesized that miR-576-5p could be a prospective therapeutic target for EC.

Analysis of Distributions of HPV Infection in Females with Cervical Lesions in the Western District of Beijing Chaoyang Hospital

Objective. To analyze the distribution of human papilloma virus (HPV) infection in women with cervical lesions of different grades and analyze the relationship of high-risk HPV and cervical lesions in order to facilitate targeted prevention. Methods. The infection status of HPV subtype was statistically analyzed in patients who underwent colposcopy examination from April 2017 to June 2019. Results. The infection rate of HPV was 81.4% in chronic cervicitis, 82.9% in 1ow-grade squamous intraepithelial lesion (LSIL), 63.7% in HSIL (high-grade squamous intraepithelial lesion), and 50% in cervical squamous cell carcinoma (CSCC). Among the 16 high-risk HPV types, the top six HPV types with the comprehensive infection rates were HPV16 > HPV52 > HPV58 > HPV18 > HPV51 > HPV53 in turn, and the infection rates were 23.3%, 14.8%, 13.3%, 9.8%, 9.2%, and 8.8%, respectively. The infection rates of HPV16 in chronic cervicitis group, LSIL group, and HSIL group were significantly different. There was no significant difference in the injection rates of HPV52, HPV58, and HPV18 among the three groups. HPV infection rates were highest in the 31–40 years old group, followed by the 41–50 years old group. Conclusion. The distribution of different types of HPV varies in different tissue types, which can be used to develop relevant vaccines to achieve better prevention and treatment of cervical cancer.

498Works
3Papers
5Collaborators

Positions

2024–

Emeritus Chair Professor of Endocrinology and Physiology

The University of Queensland · Faculty of Health, Medicine and Behavioural Sciences

1991–

Head

Prince Henry's Institute of Medical Research · Endocrine Cell Biology

1989–

Postdoctoral Research Scientist

Glaxo Research Laboratory · Analytic Pharmacology

1986–

Postdoctoral Fellow (Medical Research Foundation)

INSERM U176 · U 176

1986–

PhD student (State Doctor of France)

University of Bordeaux · Pharmacology and Neuroscience

1983–

Postgraduate Student

Institute of Basic Medical Sciences · Physiology

Education

1989

PhD

University of Bordeaux

1982

MD

Fudan University · School of Medicine

Links & IDs
0000-0003-2104-534XChen Chen

Scopus: 8789770500

Researcher Id: B-4284-2010